Research Grants & Contracts

Aphios® has been awarded several thoroughly peer-reviewed grants and contracts from the Small Business Innovative Research (SBIR) programs of the National Institutes of Health (NIH) and the National Science Foundation (NSF).

We have also been awarded two highly competitive cooperative agreements with the Advanced Technology Program (ATP), National Institute of Standards and Technology (NIST), US Department of Commerce.

Partial List of Grants and Contracts

  • Development of cGMP Manufacturing Process for CBD
    National Institute on Drug Abuse, NIH
  • Development of an SFS Fractionator
    National Center for Complementary and Alternative Medicine, NIH
  • Alzheimer's Disease Therapeutic
    National Institute on Aging, NIH
  • Biofractionation and Chemical Profiling of Devil's Claw used for RA and Back Pain
    National Center for Complementary and Alternative Medicines, NIH
  • Chemiluminescence-Photodynamic Virus Inactivation of Red Blood Cells
    National Heart, Lung and Blood Institute, NIH
  • CFI Pathogen Inactivation Technology
    National Heart, Lung and Blood Institute, NIH
  • Nanoencapsulated Camptothecin, Camposomes™ for Pancreatic Cancer
    SAIC-Frederick, Inc.
  • CFI of Human Plasma
    National Heart, Lung and Blood Institute, NIH
  • Development of Combination Anticancer Agents: Top-1 and Tdp-1 Inhibitors
    National Cancer Institute, NIH
  • 9-THC for Marijuana Addiction
    National Institute on Drug Abuse, NIH
  • Marine Microorganisms for Smallpox Therapeutics
    United States Army Medical Research Institute, DOD
  • Alkylating Vitamin D Derivative for Hormone Refractory Prostate Cancer
    National Cancer Institute, NIH
  • Development of Novel Anti-HIV Therapeutics from Marine Microorganisms
    National Institute of Allergy and Infectious Diseases, NIH
  • Anti-Smallpox Therapeutics from Marine Microorganisms
    National Center for Complementary and Alternative Medicines, NIH
  • Development of Novel Anti-Influenza Agents
    National Institute of Allergy and Infectious Diseases, NIH
  • Development of a Natural Cannabinoid Product for Cancer Pain and AIDS Wasting
    National Cancer Institute, NIH
  • SuperFluids™ Isolation of Natural Anticancer Products, Betulin and Betulinic Acid
    Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH
  • Development of Marine Anti-Plaque Compound
    National Institute of Dental and Craniofacial Research, NIH
  • Standardized and Improved Saw Palmetto Product
    National Center for Complementary and Alternative Medicine, NIH
  • Virus Inactivation Device for Medical Devices
    Food and Drug Administration
  • Development of a Controlled Release HIV Vaccine Adjuvant
    National Institute of Allergy and Infectious Diseases, NIH